Market Closed -
Nasdaq
04:00:00 2024-05-24 pm EDT
|
5-day change
|
1st Jan Change
|
23.92
USD
|
+0.42%
|
|
+3.91%
|
+203.17%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
125.1
|
388.7
|
22.3
|
88.03
|
360.8
|
-
|
-
|
Enterprise Value (EV)
1 |
125.1
|
304
|
-15.95
|
88.03
|
143.8
|
360.8
|
360.8
|
P/E ratio
|
-1.94
x
|
-2.92
x
|
-0.47
x
|
-1.28
x
|
-5.27
x
|
-5.85
x
|
-4.81
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
65.6
x
|
228
x
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
65.6
x
|
228
x
|
EV / EBITDA
|
-
|
-8,339,116
x
|
345,718
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-8.42
x
|
0.34
x
|
-
|
-2.06
x
|
-4.63
x
|
-3.52
x
|
FCF Yield
|
-
|
-11.9%
|
291%
|
-
|
-48.7%
|
-21.6%
|
-28.4%
|
Price to Book
|
-
|
4.27
x
|
0.5
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,250
|
4,952
|
4,618
|
11,158
|
15,086
|
-
|
-
|
Reference price
2 |
100.1
|
78.50
|
4.829
|
7.890
|
23.92
|
23.92
|
23.92
|
Announcement Date
|
6/8/21
|
3/18/22
|
3/8/23
|
3/4/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
5.5
|
1.582
|
EBITDA
|
-
|
-36.46
|
-46.13
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-36.83
|
-51.2
|
-68.86
|
-70.8
|
-80.97
|
-106.6
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-1,472.14%
|
-6,733.49%
|
Earnings before Tax (EBT)
1 |
-
|
-30.64
|
-37.68
|
-64.46
|
-65.26
|
-78.04
|
-104.6
|
Net income
1 |
-31.67
|
-30.64
|
-37.68
|
-64.46
|
-65.27
|
-78.03
|
-101.1
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-1,418.76%
|
-6,386.33%
|
EPS
2 |
-51.70
|
-26.90
|
-10.30
|
-6.180
|
-4.537
|
-4.089
|
-4.968
|
Free Cash Flow
1 |
-
|
-36.11
|
-46.43
|
-
|
-69.99
|
-77.88
|
-102.5
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-1,415.98%
|
-6,479.24%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/8/21
|
3/18/22
|
3/8/23
|
3/4/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-12.44
|
-11.87
|
-
|
-17.55
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-12.08
|
-12.78
|
-11.96
|
-12.71
|
-13.75
|
-13.95
|
-17.83
|
-19.36
|
-17.72
|
-15.07
|
-17.61
|
-18.6
|
-19.52
|
-16.07
|
-16.78
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-9.057
|
-2.207
|
-10.4
|
-11.86
|
-13.21
|
-14.26
|
-16.08
|
-17.54
|
-16.58
|
-13.73
|
-16.2
|
-17.06
|
-18.1
|
-16.07
|
-16.78
|
Net income
1 |
-9.057
|
-2.207
|
-10.4
|
-11.86
|
-13.21
|
-14.26
|
-16.08
|
-17.54
|
-16.58
|
-13.73
|
-16.2
|
-17.06
|
-18.1
|
-16.07
|
-16.78
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-2.500
|
-0.6000
|
-2.900
|
-3.200
|
-3.600
|
-1.600
|
-1.500
|
-1.600
|
-1.500
|
-1.030
|
-1.091
|
-1.156
|
-1.186
|
-0.8300
|
-0.8600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/22
|
5/12/22
|
8/12/22
|
11/10/22
|
3/8/23
|
5/12/23
|
8/11/23
|
11/9/23
|
3/4/24
|
5/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
84.7
|
38.3
|
-
|
217
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-36.1
|
-46.4
|
-
|
-70
|
-77.9
|
-103
|
ROE (net income / shareholders' equity)
|
-
|
-78.3%
|
-71.4%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
18.40
|
9.690
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-29.60
|
-12.60
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
2.43
|
0.58
|
0.27
|
0.58
|
0.92
|
1.5
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
16.81%
|
94.47%
|
Announcement Date
|
6/8/21
|
3/18/22
|
3/8/23
|
3/4/24
|
-
|
-
|
-
|
Last Close Price
23.92
USD Average target price
62.83
USD Spread / Average Target +162.68% Consensus |
1st Jan change
|
Capi.
|
---|
| +203.17% | 361M | | +38.51% | 727B | | +33.05% | 599B | | -6.23% | 354B | | +18.78% | 328B | | +1.35% | 277B | | +16.00% | 243B | | +8.09% | 205B | | -5.77% | 203B | | +6.19% | 164B |
Other Pharmaceuticals
|